Inflammation, homocysteine, and vitamin B6 status after ischemic stroke

Stroke. 2004 Jan;35(1):12-5. doi: 10.1161/01.STR.0000106481.59944.2F. Epub 2003 Dec 4.

Abstract

Background and purpose: Epidemiological studies have described an association between low vitamin B6 (measured as pyridoxal 5'-phosphate [PLP]) and ischemic stroke, independent of homocysteine (tHcy). We investigated B6 status, tHcy, and inflammation (measured by C-reactive protein [CRP]) in patients with stroke and controls.

Methods: Consecutive cases with new ischemic stroke were compared with matched controls. Fasting tHcy, PLP, and CRP were measured.

Results: The adjusted odds ratio of low PLP in the highest compared with the lowest CRP quartile was 16.6 (2, 139.9, P=0.01). Age, CRP, supplemental vitamin use, and albumin were independent predictors of PLP (P<0.05 for all). No relationship was observed between CRP and tHcy.

Conclusions: The relationship between inflammation and low B6 status may partially explain the findings of previous epidemiological studies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Brain Ischemia / blood*
  • Brain Ischemia / epidemiology
  • Brain Ischemia / immunology
  • C-Reactive Protein / analysis
  • Comorbidity
  • Female
  • Homocysteine / blood*
  • Humans
  • Inflammation / blood*
  • Inflammation / epidemiology
  • Inflammation / immunology
  • Male
  • Multivariate Analysis
  • Odds Ratio
  • Pyridoxal Phosphate / blood*
  • Pyridoxal Phosphate / deficiency
  • Stroke / blood*
  • Stroke / epidemiology
  • Stroke / immunology
  • Vitamin B 6 Deficiency / epidemiology*

Substances

  • Homocysteine
  • Pyridoxal Phosphate
  • C-Reactive Protein